MDMA Submits Comments on Proposed Regulation for Physician Payment "Sunshine"
Friday, February 17, 2012
After gathering input from our members and various other
stakeholders, MDMA submitted comments to the Centers for Medicare and
Medicaid Services’ (CMS) proposed rule on physician payment
disclosures. The "sunshine" regulation is a result of the Affordable
Care Act that passed in 2010, and would apply to any expenditures of $10
or more made by device and drug makers to certain health care
"The delay in publishing the draft regulation illustrated the
complexities associated with this law, which is why we are urging CMS to
provide medical device innovators more time to implement the final
rule,” said MDMA CEO and President Mark Leahey.
MDMA’s comments included:
- Increasing the timeline for implementation to 180 days
- Expanding the definition of covered recipients to include
manufacturer payments to hospital group purchasing organizations (GPOs;
- Providing information to the public about the role of innovation in physician-manufacturer collaborations.
MDMA continues to work with CMS and other policy makers to make sure the impact of this regulation does not stifle innovation.
To read the comment letter on this issue, click here.